Benzene and multiple myeloma: appraisal of the scientific evidence.

The recent paper by Bergsagel et al raised questions of scope, content, and provenance.[1][1] Goldstein and Shalat have addressed many of the issues of scope and content in their review, and a response to their letter has been received from the authors of the paper.[2][2] We will not address those